Congenital structural myopathy
MONDO:0002921A group of rare genetic muscle disorders characterized by hypotonia, muscle weakness, and delayed development of motor skills.
Also known as: centronuclear myopathy
65 clinical trials for this condition and its sub-types, 5 tagged with Congenital structural myopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Congenital structural myopathy
-
Inborn mitochondrial myopathy 18 trials · 45 incl. sub-types
24 sub-types
- Mitochondrial encephalomyopathy 3 trials · 15 incl. sub-types Sub-types →
- Progressive external ophthalmoplegia 4 trials · 8 incl. sub-types Sub-types →
- Barth syndrome 5 trials
- Mitochondrial neurogastrointestinal encephalomyopathy 4 trials Sub-types →
- Mitochondrial trifunctional protein deficiency 3 trials Sub-types →
- Myopathy, lactic acidosis, and sideroblastic anemia 3 trials Sub-types →
- Adenosine monophosphate deaminase deficiency 1 trial
- Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis 1 trial Sub-types →
- COX deficiency, benign infantile mitochondrial myopathy 0 trials
- X-linked recessive mitochondrial myopathy 0 trials
- Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy 0 trials Sub-types →
- Autosomal dominant mitochondrial myopathy with exercise intolerance 0 trials
- Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome 0 trials
- Fatal infantile encephalocardiomyopathy 0 trials Sub-types →
- Lethal infantile mitochondrial myopathy 0 trials
- Maternally-inherited progressive external ophthalmoplegia 0 trials
- Mitochondrial complex I deficiency, nuclear type 1 0 trials
- Mitochondrial complex II deficiency, nuclear type 0 trials Sub-types →
- Mitochondrial myopathy with a defect in mitochondrial-protein transport 0 trials
- Mitochondrial myopathy with diabetes 0 trials
- Mitochondrial myopathy with reversible cytochrome C oxidase deficiency 0 trials
- Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy 0 trials
- Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome 0 trials
- Mitochondrial myopathy-lactic acidosis-deafness syndrome 0 trials
-
Nemaline myopathy 13 trials
8 sub-types
- Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types Sub-types →
- Nemaline myopathy 5 2 trials
- Severe congenital nemaline myopathy 0 trials · 1 incl. sub-types Sub-types →
- MYPN-related myopathy 0 trials
- Adult-onset nemaline myopathy 0 trials
- Nemaline myopathy 5B, autosomal recessive, childhood-onset 0 trials
- Nemaline myopathy 5C, autosomal dominant 0 trials
- Typical nemaline myopathy 0 trials Sub-types →
-
Myofibrillar myopathy 1 trial · 3 incl. sub-types
13 sub-types
- Central core myopathy 2 trials
- Fatal infantile hypertonic myofibrillar myopathy 0 trials
- Myofibrillar myopathy 1 0 trials
- Myofibrillar myopathy 10 0 trials
- Myofibrillar myopathy 11 0 trials
- Myofibrillar myopathy 3 0 trials
- Myofibrillar myopathy 4 0 trials
- Myofibrillar myopathy 5 0 trials
- Myofibrillar myopathy 6 0 trials
- Myofibrillar myopathy 7 0 trials Sub-types →
- Myofibrillar myopathy 8 0 trials
- Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy 0 trials
- Myopathy, myofibrillar, 13, with rimmed vacuoles 0 trials
-
1 sub-type
Most studied deeper sub-types
-
Experimental drug aims to boost energy in rare genetic disorders
Disease control Not yet recruitingThis study tests an oral drug called glycerol tributyrate in 24 adults with MELAS or LHON-Plus, two rare mitochondrial diseases that cause severe symptoms like strokes and vision loss. The trial is open-label (everyone gets the drug) and uses each person as their own control over…
Phase 1/2 • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could your own stem cells fight this rare brain disorder?
Disease control Not yet recruitingThis study tests whether a person's own stem cells, processed and given by IV, can safely help with multiple system atrophy (MSA) — a rare, worsening brain disease that affects movement and automatic body functions like blood pressure. Fifty adults aged 35 to 65 will receive eith…
Phase 2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Hidden brain disease study aims to prevent stroke and dementia
Knowledge-focused Not yet recruitingThis study looks at people aged 65 and older who have signs of brain blood vessel disease on a past scan but no history of stroke, dementia, or other major brain conditions. Researchers will collect information on daily function, thinking skills, speech, and any new vascular even…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Rare muscle disease study aims to pave way for future treatments
Knowledge-focused Not yet recruitingThis study follows up to 10 people of any age with nemaline myopathy, a rare muscle disease, for three years. Researchers will collect information during regular hospital visits to understand how the disease changes over time. The goal is to find better ways to measure disease pr…
Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC